Outcome | AN69ST (n = 26) | PMMA (n = 26) | AN69ST vs. PMMA | |||
---|---|---|---|---|---|---|
Unadjusted 95% CI | Adjusted a 95% CI | Unadjusted P value | Adjusted a P value | |||
ICU mortality, n (%) | 13 (50.0) | 9 (34.6) | 1.89 (0.62–5.76) | 1.65 (0.48–5.85) | 0.40 | 0.42 |
28-day all-cause mortality, n (%) | 13 (50.0) | 8 (30.8) | 2.00 (0.67–6.23) | 2.34 (0.67–8.72) | 0.22 | 0.18 |
ICUFDs, median (IQR) | 0 (0–18.3) | 0 (0–16.0) | 0.99 (0.93–1.05) | – | 0.65 | – |
VAI at 48 h after CRRT initiation, median (IQR) | 0 (0–8.4) | 0 (0–15.0) | 1.01 (0.99–1.05) | – | 0.32 | – |
P/F ratio at 48 h after CRRT initiation, median (IQR) | 220 (61.4–321.0) | 227 (91.5–308) | 1.00 (0.99–1.00) | – | 0.71 | – |